Background Cannabis use is common, especially among young people, and is associated
with risks for various health harms. Some jurisdictions have recently moved to …

This narrative review represents an output from the International Association for the Study of
Pain's global task force on the use of cannabis, cannabinoids, and cannabis-based …

Importance Controlled clinical laboratory studies have shown that cannabidiol (CBD) can
sometimes attenuate or exacerbate the effects ofΔ9-tetrahydrocannabinol (Δ9-THC). No …

Background Evidence suggests cannabidiol (CBD) has anxiolytic properties, indicating
potential for novel treatment strategies. However, few clinical trials of CBD-based products …

Acute cannabis intoxication may induce neurocognitive impairment and is a possible cause
of human error, injury and psychological distress. One of the major concerns raised about …

Cannabis has been used for hundreds of years, with its ability to dampen feelings of anxiety
often reported as a primary reason for use. Only recently has the specific role cannabinoids …

Up to a third of North Americans report using cannabis in the prior month, most commonly
through inhalation. Animal models that reflect human consumption are critical to study the …

Background: Cannabis legalization is expanding, but there are no established methods for
detecting cannabis impairment. Aim: Characterize the acute impairing effects of oral and …

Blood and oral fluid Δ 9-tetrahydrocannabinol (THC) concentrations are often used to
identify cannabis-impaired drivers. We used meta-analytic techniques to characterise the …

Legalization of cannabis use for non-medical (recreational) purposes is changing the global
cannabis landscape. As attitudes toward cannabis use become more positive and …